{
  "catalogId": "28bfb0a4-95ed-45d5-acef-9a8355e1ecd4",
  "name": "VEOZA 45 MG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "176 65 37787 99",
  "treatmentDescriptions": "Veoza is indicated for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause.",
  "termsOfIssue": "Prescription required",
  "form": "film coated tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "FEZOLINETANT",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "G02CX06",
      "name": "FEZOLINETANT"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "VEOZA 45 MG 30 TAB",
      "manufacturer": {
        "name": "אסטלס",
        "countryOfOrigin": "IL"
      },
      "strength": [
        {
          "value": 45.0,
          "unit": "mg"
        }
      ],
      "quantity": {
        "value": 30.0,
        "unit": "units"
      },
      "packagingDescription": "BLISTER ALUMINIUM /ALUMINIUM",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "9496",
        "yarpa": "28853",
        "barcode": "8718692517400"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 228.922607,
        "retailMargin": 17.5,
        "maxRetailPrice": 268.9840632,
        "maxPriceWithVAT": 317.4011805
      },
      "formulation": ""
    }
  ],
  "metadata": {
    "version": "1.5",
    "lastUpdated": "2025-08-01T18:03:51.753094"
  }
}